Key result
Wearable PPG amplitude drop during standing strongly correlates with orthostatic hypotension in Parkinson's patients.
Why the study?
Cardiovascular autonomic dysfunction causes significant morbidity in Parkinson disease, but current methods for assessing orthostatic hypotension have limitations.
Does wearable chest-based photoplethysmography detect orthostatic hypotension in patients with Parkinson's disease?
Observational (n=6)
Does wearable chest-based photoplethysmography detect orthostatic hypotension in patients with Parkinson's disease?
Sternal PPG amplitude measured via a wearable chest patch may serve as a noninvasive, discriminative marker for orthostatic hypotension in patients with Parkinson's disease.
Answers are grounded in this paper and cite their sources.
Should not yet change orthostatic hypotension assessment in Parkinson's; hypothesis-generating for wearable chest-based PPG.
Orthostatic hypotension (OH) is a hallmark manifestation of cardiovascular autonomic dysfunction in Parkinson's disease (PD). Following an orthostatic stressor, OH in PD is characterized by impaired baroreflex and vasomotor function, resulting in a pathological fall in blood pressure (BP). The morbidity associated with cardiovascular autonomic dysfunction, in conjunction with the current limitations of methods for assessing OH, presents a challenging clinical and technological problem. Wearable cardiovascular sensing holds promise for improving detection and management of OH. In this study, participants with PD ( <tex xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">n=6, 3</tex> with OH) underwent an orthostatic challenge wearing a chest patch capturing electrocardiogram (ECG) and photoplethysmogram (PPG) signals alongside reference beat-to-beat BP. From supine to standing, PPG amplitude decreased significantly more ( <tex xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">p < 0.05</tex> ) in the PD+OH group compared to the PD group. Further, the change in PPG amplitude was significantly correlated ( <tex xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">r=0.83,\ p < 0.05</tex> ) to the change in pulse pressure (PP) during the orthostatic challenge. These findings suggest that sternal PPG amplitude is a potential discriminative marker of OH and may enable noninvasive detection of OH episodes, allowing for earlier diagnoses and more optimal management of cardiovascular autonomic health.
No takes yet. Share an insight, caveat, or question.
Berkebile et al. (2023) conducted an observational in Parkinson's disease with orthostatic hypotension (n=6). Wearable chest-based photoplethysmography (PPG) vs. Parkinson's disease without orthostatic hypotension was evaluated on Change in PPG amplitude from supine to standing (r=0.83, p=<0.05). Wearable chest-based PPG amplitude decreased significantly more during orthostatic challenge in Parkinson's patients with orthostatic hypotension compared to those without (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: